🟣 #ESMO2024 Segon treball de la tesi de la Dra Aida Piedra, MD, dirigida per la Dra Marga Majem #orgullsantpau

Check out the latest analysis from the PORTAL team in the October edition of our newsletter! Featuring insights on drug price negotiation, biosimilar approvals, PTAB reform, and more. mailchi.mp/3771598df509/p…

Un nou model per pronosticar la mortalitat a 90 dies de pacients oncològics que ingressen d’urgències📈 🤝🏾L’Hospital Vall d'Hebron ha desenvolupat amb la col·laboració de l’Sant Pau - Campus Salut Barcelona i l’@HospitaldelMar un model predictiu, publicat a The Lancet, que ajuda els oncòlegs a

El proper dimecres 16 d'Octubre, amb motiu del #DiaMundialContraElCàncerDeMama Sant Pau - Campus Salut Barcelona organitza la 9a edició de la Jornada per a Vosaltres. ✍️ Inscripcions: docs.google.com/forms/d/e/1FAI…

In order to ensure timely testing of drugs that have been granted accelerated approval, the FDA can impose civil monetary penalties on dilatory manufacturers — but has never done so. Read the full Perspective: nej.md/3BvjsAe

#SEOM24 La Dra.Marta Andrés presenta una comunicació oral titulada: Estudios farmacogenéticos de Palbociclib en cáncer de mama metastático receptor hormonal positivo Her2 negativo. #orgullsantpau Sant Pau - Campus Salut Barcelona Institut de Recerca Sant Pau

The federal government has proven that it can navigate the difficult process of identifying drugs for price negotiation, gathering and analyzing key information, and negotiating with manufacturers. Read the full Perspective: nej.md/48711hx

Para crear futuro hay que pensar, no hay que mimetizar La Vanguardia Banc Sabadell Serie Liderazgo lavanguardia.com/economia/20241…

Excited to participate in the first webinar of 2025 by Consilium Scientific on timely access in cancer care, clinical benefit, and value w/OncoSantPau Program On Regulation, Therapeutics, And Law

🚨New video out now! Ariadna Tibau Martorell - Timely Access in Cancer Care A seminar by Ariadna Tibau Martorell Watch here: youtu.be/WwRiLY7wNEE

📅 El pròxim dimarts 4 de febrer a les 18h. arriba una nova edició dels #SantPauTalks a la sala Francesc Cambó del Recinte Modernista de Sant Pau Recinte Modernista de Sant Pau. Coincidint amb el Dia Mundial contra el Càncer, aquest acte busca donar visibilitat a les malalties oncològiques. 💬 Amb

The English version is now online at El País English Edition (the original was in Spanish). Also, no paywall on this version. english.elpais.com/science-tech/2…

🚨New editorial by myself and Twitterless Chris Booth on the trade off between speed and clinical benefit of ca drugs receiving accelerated approval. An editorial for research from Ariadna Tibau Martorell Aaron Kesselheim Program On Regulation, Therapeutics, And Law jamanetwork.com/journals/jaman… jamanetwork.com/journals/jaman…

La Dra.Tibau ha participat al #16SimposioInternacionalGEICAM amb una revisió del posicionament de fàrmacs conjugats en #càncerdemama HER2+. GEICAM - Cáncer de mama #orgullsantpau

WATCH: Aaron Kesselheim's testimony yesterday before Ways and Means Democrats On NIH cuts - "...the next generation will look back at this moment & ask what we were doing while the Trump administration systematically disposed of 1000s of research projects that could've helped patients."

And, on strategies to improve the biosimilar market, including by implementing policies to facilitate biosimilar interchangeability, clear patent thickets, and preventing biosimilar rebate gaming by PBMs.

“The most beneficial accelerated approval drugs tend to complete confirmatory trials soonest.” Ariadna Tibau Martorell of Harvard Medical School discusses the factors associated with cancer drugs moving from U.S. FDA accelerated approval to regular approval faster. bit.ly/4lLi7rp

🔵El Dr.Barba (Andrés B.) ha publicat el 2n article de la seva tesi doctoral a IJMS MDPI ⤵️⤵️⤵️ CD274 (PD-L1) Polymorphisms as Predictors of Efficacy in First-Line Platinum-Based Chemotherapy for Extensive-Stage Small Cell Lung Cancer mdpi.com/3291986 Sant Pau - Campus Salut Barcelona

La Dra.Romano, R5 d’Oncologia Mèdica de Sant Pau - Campus Salut Barcelona, presenta un pòster al congrès americà #ASCO25! #orgullsantpau

💡New in JCP with Ariadna Tibau Martorell Aaron Kesselheim We find the time for U.S. FDA oncology indications to achieve conversion to regular approval or be withdrawn has shortened. Also, prop of confirmatory studies underway at the time of approval has increased. sciencedirect.com/science/articl…